SCHEMBL7083259

SCHEMBL7083259

CC(C)(C)OC(=O)ON1CCC(c2cccc(COC(=O)c3ccccc3)c2)C(OCc2ccc3ccccc3c2)C1

nearest known ligand 0.53

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
REN P00797 13/20 0.53
CACNA1B Q00975 1/20 0.37
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
XBP1 P17861 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GPR119 Q8TDV5 1/20 0.36
GPBAR1 Q8TDU6 1/20 0.36
CASR P41180 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7080438 0.94 REN (0.61) RENGPBAR1
SCHEMBL7079552 0.90 REN (0.41) REN
SCHEMBL7082058 0.90 REN (0.48) REN
SCHEMBL7076959 0.90 REN (0.48) REN
SCHEMBL7081144 0.89 REN (0.55) RENGPBAR1
SCHEMBL7083199 0.88 REN (0.46) REN
SCHEMBL7080945 0.88 REN (0.55) REN
SCHEMBL7080501 0.88 KDM1A (0.44) RENNPC1RAB9ASMN1; SMN2
SCHEMBL7080099 0.88 REN (0.66) RENGPBAR1
SCHEMBL7079949 0.87 REN (0.43) RENCASR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0863875-B1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY HOFFMANN LA ROCHE (CH) 2003-06-04 EP disclosed
EP-0863875-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1998-09-16 EP disclosed
WO-1997009311-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1997-03-13 WO disclosed